Vupanorsen, an N-acetyl galactosamine-conjugated antisense drug to <i>ANGPTL3</i> mRNA, lowers triglycerides and atherogenic lipoproteins in patients with diabetes, hepatic steatosis, and hypertriglyceridaemiaDaniel Gaudet, Louis O’Dea, Victoria J. Bartlett et al.|European Heart Journal|2020Cited by 276